Sign in

CIK 0001815442

  • Large accelerated filer

Kymera Therapeutics, Inc.

Sign in to watch
Ticker
KYMR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
812992166
Phone
+1 857-285-5314
Business address
500 NORTH BEACON STREET, 4TH FLOOR, WATERTOWN, MA, 02472
Former names
Kymera Therapeutics, Inc.
  1. 4 Planned sale Chief Operating Officer sold 22,240 shares at an average $85.43 ($1,900,048)
  2. 4 Planned sale Chief Operating Officer sold 115,977 shares at an average $78.02 ($9,048,290)
  3. 4 Planned sale Director sold 2,500 shares at an average $79.15 ($197,877)
  4. 4 Planned sale Chief Operating Officer sold 25,758 shares at an average $83.30 ($2,145,673)
  5. 4 Grant or award Chief Legal Officer acquired 4,125 shares (grant or award)
  6. 4 Open-market sale Chief Operating Officer sold 5,958 shares at an average $86.54 ($515,594)
  7. 4 Grant or award Chief Business Officer acquired 9,225 shares (grant or award)
  8. 4 Open-market sale Chief Medical Officer sold 10,508 shares at an average $87.24 ($916,669)
  9. 4 Open-market sale Chief Financial Officer sold 12,471 shares at an average $87.50 ($1,091,231)
  10. 4 Derivatives Options or other derivatives
  11. 4 Planned sale Director sold 81,866 shares at $90.13 ($7,378,583)
  12. 4 Planned sale Chief Executive Officer sold 30,000 shares at an average $90.26 ($2,707,813)
  13. 4 Planned sale Director sold 2,500 shares at an average $87.31 ($218,270)
  14. 4 Planned sale Director sold 5,500 shares at an average $67.91 ($373,521)
  15. 4 Exercise or conversion Chief Executive Officer acquired 3,118 shares (option exercise)
  16. 4 Planned sale Chief Executive Officer sold 30,000 shares at an average $78.06 ($2,341,939)
  17. 4 Exercise or conversion Chief Executive Officer acquired 2,595 shares (option exercise)
  18. 4 Planned sale Director sold 27,563 shares at an average $82.16 ($2,264,480)
  19. 4 Open-market sale Director sold 236,588 shares at an average $91.72 ($21,699,044)
  20. 4 Open-market buy Director bought 2,005,813 shares at $86.00 ($172,499,918)

Page 3 of 15 · 296 filings